Brophebarbital
Chemical compound
- none
- CA: Schedule IV
- 5-Ethyl-5-(3-bromophenyl)-1,3-diazinane-2,4,6-trione
- 3865-10-9 Y
- 27289066 N
- LAD0UT1E4E
- DTXSID50726647
- Interactive image
- Brc2cccc(c2)C1(CC)C(=O)NC(=O)NC1=O
InChI
- InChI=1S/C12H11BrN2O3/c1-2-12(7-4-3-5-8(13)6-7)9(16)14-11(18)15-10(12)17/h3-6H,2H2,1H3,(H2,14,15,16,17,18) N
- Key:DFTKCGKSDZVCTO-UHFFFAOYSA-N N
Brophebarbital is a barbiturate derivative. It has sedative and hypnotic effects and is considered to have a moderate abuse potential.[1]
References
- ^ Eddy NB, Halbach H, Isbell H, Seevers MH (1965). "Drug dependence: its significance and characteristics". Bulletin of the World Health Organization. 32 (5): 721–33. PMC 2555251. PMID 5294186.
- v
- t
- e
Hypnotics/sedatives (N05C)
Antihistamines | |
---|---|
Antidepressants | |
Antipsychotics |
Antidepressants | |
---|---|
Antipsychotics | |
Others |
- Agomelatine
- Melatonin
- Ramelteon
- Tasimelteon
- Cannabidiol
- Cannabis
- Chlorophenylalkyldiols
- Diethylpropanediol
- Evoxine
- Fenadiazole
- Guaifenesin-related muscle relaxants
- Midaflur
- Opioids (e.g., morphine)
- Passion flower
- Scopolamine
- Trazodone
- UMB68
- Valnoctamide
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e